BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24401748)

  • 1. miR-34a is essential for p19(Arf)-driven cell cycle arrest.
    Iqbal N; Mei J; Liu J; Skapek SX
    Cell Cycle; 2014; 13(5):792-800. PubMed ID: 24401748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p19Arf represses platelet-derived growth factor receptor β by transcriptional and posttranscriptional mechanisms.
    Widau RC; Zheng Y; Sung CY; Zelivianskaia A; Roach LE; Bachmeyer KM; Abramova T; Desgardin A; Rosner A; Cunningham JM; Skapek SX
    Mol Cell Biol; 2012 Nov; 32(21):4270-82. PubMed ID: 22907756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p19(Arf) limits primary vitreous cell proliferation driven by PDGF-B.
    Iqbal NS; Devitt CC; Sung CY; Skapek SX
    Exp Eye Res; 2016 Apr; 145():224-229. PubMed ID: 26778750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARF sees Pdgfrβ through the miR.
    Reed SM; Quelle FW; Quelle DE
    Cell Cycle; 2014; 13(10):1520-1. PubMed ID: 24755551
    [No Abstract]   [Full Text] [Related]  

  • 5. The Arf tumor suppressor regulates platelet-derived growth factor receptor beta signaling: a new view through the eyes of Arf(-/-) mice.
    Thornton JD; Silva RL; Martin AC; Skapek SX
    Cell Cycle; 2005 Oct; 4(10):1316-9. PubMed ID: 16205116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arf-dependent regulation of Pdgf signaling in perivascular cells in the developing mouse eye.
    Silva RL; Thornton JD; Martin AC; Rehg JE; Bertwistle D; Zindy F; Skapek SX
    EMBO J; 2005 Aug; 24(15):2803-14. PubMed ID: 16037818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p19(Arf) is required for the cellular response to chronic DNA damage.
    Bieging-Rolett KT; Johnson TM; Brady CA; Beaudry VG; Pathak N; Han S; Attardi LD
    Oncogene; 2016 Aug; 35(33):4414-21. PubMed ID: 26725325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p19ARF-induced p53-independent apoptosis largely occurs through BAX.
    Suzuki H; Kurita M; Mizumoto K; Nishimoto I; Ogata E; Matsuoka M
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1273-7. PubMed ID: 14652011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
    Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53-independent apoptosis is induced by the p19ARF tumor suppressor.
    Tsuji K; Mizumoto K; Sudo H; Kouyama K; Ogata E; Matsuoka M
    Biochem Biophys Res Commun; 2002 Jul; 295(3):621-9. PubMed ID: 12099684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small mitochondrial Arf (smArf) protein corrects p53-independent developmental defects of
    van Oosterwijk JG; Li C; Yang X; Opferman JT; Sherr CJ
    Proc Natl Acad Sci U S A; 2017 Jul; 114(28):7420-7425. PubMed ID: 28652370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential p53-independent outcomes of p19(Arf) loss in oncogenesis.
    Chen Z; Carracedo A; Lin HK; Koutcher JA; Behrendt N; Egia A; Alimonti A; Carver BS; Gerald W; Teruya-Feldstein J; Loda M; Pandolfi PP
    Sci Signal; 2009 Aug; 2(84):ra44. PubMed ID: 19690330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
    Shin J; Yang J; Lee JC; Baek KH
    Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways.
    Kelly-Spratt KS; Gurley KE; Yasui Y; Kemp CJ
    PLoS Biol; 2004 Aug; 2(8):E242. PubMed ID: 15314658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest.
    Rowland BD; Denissov SG; Douma S; Stunnenberg HG; Bernards R; Peeper DS
    Cancer Cell; 2002 Jul; 2(1):55-65. PubMed ID: 12150825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
    Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
    Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arf tumor suppressor and miR-205 regulate cell adhesion and formation of extraembryonic endoderm from pluripotent stem cells.
    Li C; Finkelstein D; Sherr CJ
    Proc Natl Acad Sci U S A; 2013 Mar; 110(12):E1112-21. PubMed ID: 23487795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phytochemical regulation of the tumor suppressive microRNA, miR-34a, by p53-dependent and independent responses in human breast cancer cells.
    Hargraves KG; He L; Firestone GL
    Mol Carcinog; 2016 May; 55(5):486-98. PubMed ID: 25789847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential manifestation of ocular phenotypes in TALEN-mediated p19
    Park JS; Kim JI; Lim HJ; Ryu SK; Kwon E; Han KM; Nam KT; Lee HW; Kang BC
    Genes Genomics; 2020 Sep; 42(9):1023-1033. PubMed ID: 32712838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
    Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
    Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.